Jane Street Group, LLC Recursion Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 238,033 shares of RXRX stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

238,033

Previous 575,233 58.62%

Holding current value

$1.77 Million

Previous $4.31 Million 63.65%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.92 - $8.6 $2 Million - $2.9 Million	-337,200 Reduced 58.62%	238,033 $1.57 Million
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $2.67 Million - $3.65 Million	363,283 Added 171.4%	575,233 $4.31 Million
Q1 2024 May 15, 2024	SELL	$9.13 - $15.52 $1.19 Million - $2.03 Million	-130,711 Reduced 38.15%	211,950 $2.11 Million
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $1.56 Million - $3.31 Million	307,097 Added 863.51%	342,661 $3.38 Million
Q3 2023 Nov 14, 2023	SELL	$6.59 - $15.86 $460,891 - $1.11 Million	-69,938 Reduced 66.29%	35,564 $272,000
Q2 2023 Aug 14, 2023	BUY	$4.56 - $9.94 $48,021 - $104,678	10,531 Added 11.09%	105,502 $788,000
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $435,776 - $654,343	67,878 Added 250.54%	94,971 $633,000
Q4 2022 Feb 14, 2023	SELL	$7.16 - $12.7 $53,205 - $94,373	-7,431 Reduced 21.52%	27,093 $208,000
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $83,632 - $145,261	10,681 Added 44.8%	34,524 $367,000
Q2 2022 Aug 16, 2022	BUY	$5.04 - $9.26 $49,775 - $91,451	9,876 Added 70.71%	23,843 $194,000
Q1 2022 May 17, 2022	SELL	$6.16 - $18.03 $25,243 - $73,886	-4,098 Reduced 22.68%	13,967 $100,000
Q4 2021 Feb 15, 2022	BUY	$16.14 - $21.86 $291,569 - $394,900	18,065 New	18,065 $309,000

Others Institutions Holding RXRX

# of Institutions

287

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.34B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Recursion Pharmaceuticals, Inc. Transaction History